等待开盘 02-05 09:30:00 美东时间
+0.120
+1.12%
今日重点评级关注:Canaccord Genuity:维持Wave Life Sciences Ltd."买入"评级,目标价从40美元升至43美元;花旗:维持Palantir Technologies"买入"评级,目标价从235美元升至260美元
02-04 12:15
Wedbush analyst Michael Piccolo initiates coverage on TaskUs (NASDAQ:TASK) with a Outperform rating and announces Price Target of $15.
02-04 00:23
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
2025-11-11 10:49
Taskus, Inc. Class A (($TASK)) has held its Q3 earnings call. Read on for the m...
2025-11-09 08:26
TaskUs shares are trading higher after the company reported better-than-expecte...
2025-11-07 22:23
Fourth Quarter and Full Year 2025 OutlookFor the fourth quarter and full year 2025 TaskUs expects its financial results to include: 2025 Outlook Fourth Quarter Full YearRevenue (in millions)$302.4 to
2025-11-07 20:21
Fourth Quarter and Full Year 2025 OutlookFor the fourth quarter and full year 2025 TaskUs expects its financial results to include: 2025 Outlook Fourth Quarter Full YearRevenue (in millions)$302.4 to
2025-11-07 20:20
TaskUs (NASDAQ:TASK) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.38 by 9.95 percent. This is a 13.51 percent increase over earnings of $0.37 per share from the same
2025-11-07 20:03
Companies Reporting Before The Bell • Kiora Pharmaceuticals (NASDAQ:KPRX) is pr...
2025-11-07 19:11
TaskUs (NASDAQ:TASK) is gearing up to announce its quarterly earnings on Friday...
2025-11-07 01:03